Global Medical REIT Inc. (GMRE)

NYSE: GMRE · IEX Real-Time Price · USD
12.13
+0.16 (1.38%)
Aug 12, 2022 2:49 PM EDT - Market open

Ratios and Metrics (Trailing)

Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ending Current2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Market Capitalization
8457361,0671,14094489768462962451044848140436325819620419215017719415716015717214
Market Cap Growth
--18.00%56.04%81.09%51.14%75.95%52.70%30.79%54.74%40.56%73.40%145.73%98.04%89.32%71.83%10.40%4.90%21.76%-5.96%12.95%13.04%991.24%----
Enterprise Value
1,4911,3811,6451,6991,4861,3921,1581,2051,13796389686080071151450653251241137135032631720313091
PE Ratio
67.3659.3984.0096.58104.15-183.28-94.40-81.24-82.18148.25108.19141.0343.6841.4533.1825.54462.04357.55-6.00-101.24-55.67-26.89-27.93-24.72-32.96-3.87
PS Ratio
6.725.848.869.838.548.496.886.717.006.195.806.806.246.004.553.684.184.454.045.858.239.1513.8319.1329.913.41
PB Ratio
1.331.161.671.831.531.441.181.421.441.191.081.121.181.100.760.730.860.810.620.720.770.891.071.011.081.19
P/OCF Ratio
11.159.7115.2216.5313.9220.5218.2218.2322.1911.6910.5313.2112.4513.6511.917.898.758.648.0314.0823.3646.6275.35---
EV/Sales Ratio
11.8410.4313.5014.5113.0112.9812.6712.1812.0711.6310.7112.4011.6310.2210.009.8510.7710.499.3110.9815.3818.3117.8114.0343.2822.00
EV/EBITDA Ratio
19.8717.5122.1723.6521.4726.6926.9926.2425.8518.9816.9019.1215.2813.1912.7712.4416.5816.6116.0121.7440.7488.17123.41952.32496.03107.33
EV/EBIT Ratio
39.1834.5242.8145.0841.2965.5670.3168.1364.8935.0429.7632.8523.4619.8919.0018.4127.4528.0228.5045.04132.96-----
Debt / Equity Ratio
1.041.040.920.920.900.810.831.321.201.091.120.901.181.070.761.171.401.371.100.810.651.041.120.430.256.62
Debt / EBITDA Ratio
8.798.797.998.048.289.8710.3913.4812.469.249.498.428.177.565.817.4810.4912.0212.3713.1018.4851.21100.61549.8780.4892.72
Debt / FCF Ratio
-6.27-6.27-5.46-4.55-3.07-2.36-3.11-3.19-2.82-2.69-1.77-1.74-2.43-3.04-3.01-2.49-2.18-1.57-1.40-0.84-0.57-0.71-0.76-0.44-0.44-1.14
Asset Turnover
0.100.100.100.100.090.100.090.090.090.090.090.090.090.090.090.090.090.080.080.080.070.060.050.050.05-
Return on Equity (ROE)
2.00%2.00%2.00%1.90%1.60%-0.90%-1.50%-1.80%-1.80%0.90%1.10%0.90%2.90%3.00%2.90%3.10%0.20%0.20%0.00%-0.90%-1.90%-3.70%-4.80%-7.50%-11.30%-
Return on Assets (ROA)
1.00%1.00%1.00%1.00%0.80%-0.40%-0.70%-0.80%-0.80%0.40%0.50%0.40%1.30%1.30%1.20%1.30%0.10%0.10%0.00%-0.40%-1.00%-2.10%-2.70%-4.00%-4.50%-
Return on Capital (ROIC)
2.00%2.00%2.10%2.20%2.10%1.30%1.20%1.10%1.20%2.10%2.20%2.40%3.10%3.20%3.20%3.20%2.30%2.20%1.90%1.30%0.60%-0.30%-0.60%-1.10%-0.80%-
Earnings Yield
1.47%1.68%1.19%1.03%0.96%-0.55%-1.06%-1.23%-1.22%0.68%0.92%0.71%2.29%2.41%3.01%3.92%0.22%0.28%-0.01%-0.99%-1.80%-3.72%-3.58%-4.04%-3.03%-25.85%
FCF Yield
-12.44%-14.30%-10.06%-11.02%-19.16%-23.94%-22.77%-29.25%-29.45%-33.95%-58.51%-46.08%-40.94%-32.16%-33.27%-64.72%-74.79%-108.48%-126.95%-135.30%-147.97%-163.68%-137.67%-97.21%-53.01%-486.76%
Dividend Yield
8.54%7.39%5.05%4.36%5.54%5.52%6.20%5.88%6.01%7.12%7.89%5.63%7.04%7.62%8.48%8.98%8.56%9.03%11.51%8.85%8.86%8.97%6.61%2.37%2.02%-
Payout Ratio
436.80%436.80%412.50%431.60%543.30%-623.10%-473.50%-470.60%-500.00%1000.00%727.30%800.00%205.10%210.50%228.60%228.60%4000.00%2666.70%-8000.00%-888.90%-888.90%-363.60%-113.20%-58.80%-3.00%0.00%
Buyback Yield / Dilution
-7.05%-7.05%-23.98%-31.10%-36.87%-34.78%-19.21%-36.59%-32.09%-31.38%-61.37%-54.13%-62.92%-59.77%-26.58%-12.00%-1.28%-22.60%-22.86%-110.89%-23.89%-1136.74%-2717.06%-3620.80%-6848.70%-
Total Shareholder Return
1.49%0.34%-18.93%-26.73%-31.33%-29.25%-13.01%-30.71%-26.08%-24.26%-53.47%-48.50%-55.88%-52.15%-18.10%-3.02%7.28%-13.57%-11.35%-102.04%-15.03%-1127.77%-2710.45%-3618.43%-6846.68%0.00%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).